Karla V. Ballman

2003–2025 年に発表

別表記
Karla V Ballman
164
論文数
35,020
被引用数
90
h 指数
160
i10 指数

被引用数

Karla V. Ballman の年別被引用数1986 年: 被引用 1 件1993 年: 被引用 1 件2003 年: 被引用 3 件2004 年: 被引用 37 件2005 年: 被引用 65 件2006 年: 被引用 121 件2007 年: 被引用 188 件2008 年: 被引用 216 件2009 年: 被引用 223 件2010 年: 被引用 246 件2011 年: 被引用 227 件2012 年: 被引用 234 件2013 年: 被引用 245 件2014 年: 被引用 247 件2015 年: 被引用 325 件2016 年: 被引用 311 件2017 年: 被引用 347 件2018 年: 被引用 295 件2019 年: 被引用 1,057 件2020 年: 被引用 1,197 件2021 年: 被引用 1,159 件2022 年: 被引用 875 件2023 年: 被引用 653 件2024 年: 被引用 1,096 件2025 年: 被引用 490 件2026 年: 被引用 20 件1987〜1992 年は被引用が無いため表示していません1994〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,417 件、この内訳の 29.4%中国: 引用元論文 1,106 件、この内訳の 7.4%イギリス: 引用元論文 949 件、この内訳の 6.3%ドイツ: 引用元論文 784 件、この内訳の 5.2%イタリア: 引用元論文 747 件、この内訳の 5%カナダ: 引用元論文 700 件、この内訳の 4.6%フランス: 引用元論文 558 件、この内訳の 3.7%オランダ: 引用元論文 545 件、この内訳の 3.6%スイス: 引用元論文 422 件、この内訳の 2.8%スペイン: 引用元論文 400 件、この内訳の 2.7%オーストラリア: 引用元論文 362 件、この内訳の 2.4%日本: 引用元論文 359 件、この内訳の 2.4%
0%29.4%その他 24.5%

分野

  • Medicine69.4%
  • Biochemistry, Genetics and Molecular Biology23.9%
  • Immunology and Microbiology2.2%
  • Computer Science0.9%
  • Engineering0.5%
  • Neuroscience0.5%
  • その他2.6%

トピック

  • Glioma Diagnosis and Treatment5%
  • Breast Cancer Treatment Studies4.1%
  • Brain Metastases and Treatment3.6%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Cancer Genomics and Diagnostics2.3%
  • Breast Lesions and Carcinomas2.3%
  • その他80%

共著者

全論文

検索で開く
  1. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

    著者: , , , , , , , , , , , , , - JAMA 2017 被引用: 1,862

  2. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

    著者: , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 1,661

  3. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 被引用: 1,192

  4. Somatic mutations precede acute myeloid leukemia years before diagnosis

    著者: , , , , , , , , , , , - Nature Medicine 2018 被引用: 615

  5. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 330

  6. Clinical features of neuroendocrine prostate cancer

    著者: , , , , , , , , , , , , , - European Journal of Cancer 2019 被引用: 363

  7. Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

    著者: , , , , , , , , , , , , , , , , , , - PLoS ONE 2013 被引用: 665

  8. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 275

  9. Obstructive Sleep Apnea and the Risk of Sudden Cardiac Death

    著者: , , , , , , , , - Journal of the American College of Cardiology 2013 被引用: 609

  10. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Salvatore Piscuoglio, Mark A. Rubin - Nature Communications 2020 被引用: 148

  11. Biomarker: Predictive or Prognostic?

    著者: - Journal of Clinical Oncology 2015 被引用: 492

  12. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cecilia Mitchell, Alan W.C. Tan, Howard Streicher, Elad Sharon, Helen Moon, Michael Woods, Susan Halabi, Gabriela Perez Burbano, Michael J. Morris, Jonathan E. Rosenberg - New England Journal of Medicine 2024 被引用: 145

  13. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

    著者: , , , , , , , , , - Annals of Surgery 2010 被引用: 1,254

  14. Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , - JAMA Oncology 2023 被引用: 75

  15. Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 67

  16. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial

    著者: , , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2011 被引用: 762

  17. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy

    著者: , , , , , , , , , - Annals of Surgery 2015 被引用: 453

  18. Whole-genome analysis informs breast cancer response to aromatase inhibition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie A. Margenthaler, Gildy V. Babiera, P. Kelly Marcom, J. Michael Guenther, Marilyn Leitch, Kelly K. Hunt, John A. Olson, Tao Yu, Christopher A. Maher, Lucinda Fulton, Robert S. Fulton, Michelle Harrison, Ben Oberkfell, Feiyu Du, Ryan Demeter, Tammi L. Vickery, Adnan Elhammali, Helen Piwnica‐Worms, Sandra McDonald, Mark A. Watson, David J. Dooling, David M. Ota, Li-Wei Chang, Ron Bose, Timothy J. Ley, David Piwnica‐Worms, Joshua M. Stuart, Richard K. Wilson, Elaine R. Mardis - Nature 2012 被引用: 1,035

  19. Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer

    著者: , , , , , , , , , - Annals of Surgery 2014 被引用: 432

  20. Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

    著者: , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2017 被引用: 134

  21. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

    著者: , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2020 被引用: 115

  22. Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation

    著者: , , , , , , , - Circulation 2003 被引用: 976

  23. Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 145

  24. Precision Oncology: An Overview

    著者: , , - Journal of Clinical Oncology 2013 被引用: 403